Database Update: Pharmaceutical Drug Import to Russia (January 2017)
In January 2017, Russia imported 29.8 bln RUB worth of ready-made drugs (free circulation prices) and 6.8 bln RUB worth of in-bulk drugs, which are 20% and 90% higher than those of the same period of 2016, respectively. We saw the dynamics of the in-bulk import as high 8 months ago.
In physical terms, the import of ready-made drugs amounted to 125.8 mln units, with a 19% annual dynamics. In January, Russia imported 2.74 bln minimum dosage units (MDU), which is 27% higher than that of the same period of 2016. Over the past 13 months, only August has shown the better dynamics.
In January 2017, the number of payments in rubles increased, with 95.8% of all imports of ready-made and in-bulk drugs being payed for in rubles, which is 2.5% higher than last year. The number of payments in euros has dropped the most – by 1.7%. The British pound was not used at all, while the Japanese yena has a big chance to become one of the regular payment currencies. Citibank processed the biggest number of payments (50%), which is 38% higher than last year. Sberbank comes second with 9% and a 3% increase.
Read more about pharmaceutical drug import to Russia (December performance) here:http://rncph.com/news/19_01_2017
Dynamics of import of pharmaceuticals, including homeopathic and seawater drugs, to Russia, free circulation prices including customs clearance, RUB (January 2016 – January 2017))